Role of the NLRP3 inflammasome in cancer.
Moossavi M, Parsamanesh N, Bahrami A, Atkin SL, Sahebkar A. · 2018
Read Role of the NLRP3 inflammasome in cancer. by Moossavi M, Parsamanesh N, Bahrami A, Atkin SL, Sahebkar A. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6240225.txt.
Description
Moossavi and co-authors review the NLRP3 inflammasome in cancer. Inflammasomes are large protein complexes inside cells. They form in response to danger signals. They activate enzymes that switch on inflammation. The review appeared in Molecular Cancer.
The complex pairs a Nod-like receptor with adapter and caspase proteins. Its activation releases active IL-1b and IL-18. Faulty control of NLRP3 is linked to tumour growth. Yet study findings on its role conflict. It may promote cancer in some settings. It may restrain cancer in others. The authors sum up current knowledge on both sides. They also cover its promise as a therapy target. Clarifying this dual role is a key next step.
Catalog record
| CREATOR | Moossavi M, Parsamanesh N, Bahrami A, Atkin SL, Sahebkar A. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 72 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |